New guidelines released by the Alzheimer’s Association and the National Institutes of Health and the National Institute of Aging identify new diagnostic criteria and new biomarkers for Alzheimer’s disease. The guidelines identify previously unrecognized phases of the disease. The three new phases refer to the disease’s progression, starting before well-known...